Vedolizumab: Real-life outcomes to therapy in Crohn's disease-MedSci.cn

Vedolizumab: Real-life outcomes to therapy in Crohn's disease

Pulusu, SSR; Krishnaprasad, K; Cheng, D; Mogilevski, T; Flanagan, E; Parthasarathy, N; Wu, C; Prosser, R; Sawyer, E; Rizvi, QUA; Taylor, K; Cooke, S; Mahy, G; Sparrow, M; Andrews, J; Connor, S; Bampton, P; Ghaly, S; Van Langenberg, D; Bell, S; De Cru

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017; 32 ( ): 143

科室
- - 订阅+
  - 更多科室
工具
服务